trimethoprim--sulfamethoxazole-drug-combination and Scurvy

trimethoprim--sulfamethoxazole-drug-combination has been researched along with Scurvy* in 1 studies

Other Studies

1 other study(ies) available for trimethoprim--sulfamethoxazole-drug-combination and Scurvy

ArticleYear
From past sailors' eras to the present day: scurvy as a surprising manifestation of an uncommon gastrointestinal disease.
    BMJ case reports, 2015, Sep-16, Volume: 2015

    A 45-year-old man presented with follicular exanthema in his lower limbs, alternating bowel habits and significant weight loss. His medical history included seronegative arthritis, bipolar disease and an inconclusive diagnostic laparoscopy. Diagnostic work up revealed microcytic anaemia and multivitamin deficiency. Skin biopsy of the exanthema suggested scurvy. Owing to these signs of malabsorption, upper endoscopy with duodenal biopsies was performed, exhibiting villous atrophy and extensive periodic acid-Schiff-positive material in the lamina propria, therefore diagnosing Whipple's disease (WD). After starting treatment with ceftriaxone and co-trimoxazole, an impressive recovery was noted, as the wide spectrum of malabsorption signs quickly disappeared. After a year of antibiotics, articular and cutaneous manifestations improved, allowing the patient to stop taking corticosteroids and antidepressants. This truly unusual presentation reflects the multisystemic nature of WD, often leading to misdiagnosis of other entities. Scurvy is a rare finding in developed countries, but its presence should raise suspicion for small bowel disease.

    Topics: Anti-Bacterial Agents; Biopsy; Ceftriaxone; Diagnostic Errors; Exanthema; Follow-Up Studies; Humans; Middle Aged; Scurvy; Skin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Tropheryma; Whipple Disease

2015